ABCB1 and ovarian carcinoma: Another advantage of HA-PEI/HA-PEG nanoparticle is the potential of increased cellular uptake of MDR1 siRNA in MDR ovarian cancer cells via targeted delivery through HA-CD44 receptor interaction.